Lv1
16 积分 2025-06-30 加入
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
56分钟前
待确认
Randomized, Phase III Trial of Mixed Formulation of Fosrolapitant and Palonosetron (HR20013) in Preventing Cisplatin-Based Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: PROFIT
3天前
已完结
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
3个月前
已完结
Randomized, Phase III Trial of Mixed Formulation of Fosrolapitant and Palonosetron (HR20013) in Preventing Cisplatin-Based Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: PROFIT
4个月前
已完结
Influence of Lymphadenectomy Extent on the Efficacy of Immunotherapy in Recurrent Gastric Cancer Patients
9个月前
已完结
The efficacy of time interval between neoadjuvant chemoimmunotherapy and surgery on outcomes in esophageal squamous cell carcinoma
9个月前
已完结
Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer
10个月前
已完结
Prediction of breakthrough pain during labour neuraxial analgesia: comparison of machine learning and multivariable regression approaches
11个月前
已完结
皖公网安备34019202002308
